HENRY SCHEIN, INC. (HSIC) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-27..
- Stock-based compensation / revenue · 12 months: Value 0.29%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-27..
- Interest coverage · 12 months: Value 4.28×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-27; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-27. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.29% | Share-based compensation / revenue. Period ending 2026-06-27. $39.00M ÷ $13.60B × 100 ≈ 0.29% |
| Interest coverage · 12 months | 4.28× | Operating income ÷ reported interest expense. $680.00M ÷ $159.00M ≈ 4.28× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 13.60B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 39.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 680.00M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 159.00M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | (m) | $13.60B | $39.00M | $680.00M | $159.00M | (m) | 0.29% | 4.28× | Reported |
| 2026-03-28 | (m) | $13.38B | $37.00M | $660.00M | $154.00M | (m) | 0.28% | 4.29× | Reported |
| 2025-12-27 | (m) | $13.18B | $39.00M | $653.00M | $150.00M | (m) | 0.30% | 4.35× | Reported |
| 2025-09-27 | (m) | $12.94B | $38.00M | $645.00M | $146.00M | (m) | 0.29% | 4.42× | Reported |
| 2025-06-28 | (m) | $12.77B | $35.00M | $638.00M | $142.00M | (m) | 0.27% | 4.49× | Reported |
| 2025-03-29 | (m) | $12.67B | $36.00M | $646.00M | $136.00M | (m) | 0.28% | 4.75× | Reported |
| 2024-12-28 | (m) | $12.67B | $39.00M | $621.00M | $131.00M | (m) | 0.31% | 4.74× | Reported |
| 2024-09-28 | (m) | $12.50B | $31.00M | $505.00M | $125.00M | (m) | 0.25% | 4.04× | Reported |
| 2024-06-29 | (m) | $12.49B | $35.00M | $548.00M | $116.00M | (m) | 0.28% | 4.72× | Reported |
| 2024-03-30 | (m) | $12.45B | $37.00M | $590.00M | $103.00M | (m) | 0.30% | 5.73× | Reported |
| 2023-12-30 | (m) | $12.34B | $39.00M | $615.00M | $87.00M | (m) | 0.32% | 7.07× | Reported |
| 2023-09-30 | (m) | $12.69B | $48.00M | $648.00M | $79.00M | (m) | 0.38% | 8.20× | Reported |
| 2023-07-01 | (m) | $12.60B | $51.00M | $659.00M | $62.00M | (m) | 0.40% | 10.63× | Reported |
| 2023-04-01 | (m) | $12.53B | $52.00M | $678.00M | $51.00M | (m) | 0.42% | 13.29× | Reported |
| 2022-12-31 | (m) | $12.65B | $54.00M | $747.00M | $44.00M | (m) | 0.43% | 16.98× | Reported |
| 2022-09-24 | (m) | $12.61B | $64.42M | $875.66M | $34.60M | (m) | 0.51% | 25.31× | Reported |
| 2022-06-25 | (m) | $12.72B | $75.42M | $875.66M | $30.60M | (m) | 0.59% | 28.62× | Reported |
| 2022-03-26 | (m) | $12.66B | $77.42M | $865.66M | $28.60M | (m) | 0.61% | 30.27× | Reported |
| 2021-12-25 | (m) | $12.40B | $78.42M | $851.66M | $27.60M | (m) | 0.63% | 30.86× | Reported |
| 2021-09-25 | (m) | $12.24B | $73.14M | $832.29M | $31.38M | (m) | 0.60% | 26.52× | Reported |
| 2021-06-26 | (m) | $11.90B | $51.30M | $809.14M | $35.94M | (m) | 0.43% | 22.51× | Reported |
| 2021-03-27 | (m) | $10.62B | $39.09M | $591.37M | $40.05M | (m) | 0.37% | 14.77× | Reported |
| 2020-12-26 | (m) | $10.12B | $8.79M | $535.30M | $41.38M | (m) | 0.09% | 12.94× | Reported |
| 2020-09-26 | (m) | $9.62B | $5.16M | $550.44M | $38.74M | (m) | 0.05% | 14.21× | Reported |
| 2020-06-27 | (m) | $9.29B | $12.79M | $549.96M | $40.00M | (m) | 0.14% | 13.75× | Reported |
| 2020-03-28 | (m) | $10.05B | $20.30M | $719.68M | $42.30M | (m) | 0.20% | 17.01× | Reported |
| 2019-12-28 | (m) | $9.99B | $44.92M | $718.26M | $50.79M | (m) | 0.45% | 14.14× | Reported |
| 2019-09-28 | (m) | $13.57B | $38.78M | $832.36M | $65.68M | (m) | 0.29% | 12.67× | Reported |
| 2019-06-29 | (m) | $13.42B | $34.96M | $768.43M | $73.73M | (m) | 0.26% | 10.42× | Reported |
| 2019-03-30 | (m) | $13.29B | $35.65M | $763.25M | $78.18M | (m) | 0.27% | 9.76× | Reported |
| 2018-12-29 | (m) | $13.20B | $36.24M | $753.05M | $78.79M | (m) | 0.27% | 9.56× | Reported |
| 2018-09-29 | (m) | $13.14B | $44.54M | $814.61M | $73.06M | (m) | 0.34% | 11.15× | Reported |
| 2018-06-30 | (m) | $13.03B | $46.28M | $862.23M | $65.45M | (m) | 0.36% | 13.17× | Reported |
| 2018-03-31 | (m) | $12.76B | $42.55M | $871.54M | $59.76M | (m) | 0.33% | 14.58× | Reported |
| 2017-12-30 | (m) | $12.46B | $42.29M | $859.37M | $53.65M | (m) | 0.34% | 16.02× | Reported |
| 2017-09-30 | (m) | $12.26B | $46.61M | $832.16M | $46.97M | (m) | 0.38% | 17.72× | Reported |
| 2017-07-01 | (m) | $11.97B | $50.15M | $819.33M | $41.03M | (m) | 0.42% | 19.97× | Reported |
| 2017-04-01 | (m) | $11.78B | $52.60M | $789.35M | $36.20M | (m) | 0.45% | 21.81× | Reported |
| 2016-12-31 | (m) | $11.57B | $58.25M | $771.57M | $31.89M | (m) | 0.50% | 24.19× | Reported |
| 2016-09-24 | (m) | $11.30B | $53.16M | $758.28M | $29.14M | (m) | 0.47% | 26.02× | Reported |
| 2016-06-25 | (m) | $11.12B | $50.07M | $746.45M | $27.95M | (m) | 0.45% | 26.71× | Reported |
| 2016-03-26 | (m) | $10.88B | $50.26M | $748.80M | $26.87M | (m) | 0.46% | 27.87× | Reported |
| 2015-12-26 | (m) | $10.63B | $44.61M | $733.97M | $26.01M | (m) | 0.42% | 28.22× | Reported |
| 2015-09-26 | (m) | $10.48B | $47.70M | $736.22M | $25.70M | (m) | 0.46% | 28.65× | Reported |
| 2015-06-27 | (m) | $10.42B | $48.37M | $721.43M | $25.68M | (m) | 0.46% | 28.09× | Reported |
| 2015-03-28 | (m) | $10.40B | $45.41M | $719.24M | $25.06M | (m) | 0.44% | 28.70× | Reported |
| 2014-12-27 | (m) | $10.37B | $45.88M | $715.14M | $24.06M | (m) | 0.44% | 29.73× | Reported |
| 2014-09-27 | (m) | $10.20B | $44.08M | $699.08M | $22.08M | (m) | 0.43% | 31.66× | Reported |
| 2014-06-28 | (m) | $9.92B | $38.30M | $685.47M | $20.85M | (m) | 0.39% | 32.88× | Reported |
| 2014-03-29 | (m) | $9.70B | $39.18M | $680.69M | $20.07M | (m) | 0.40% | 33.92× | Reported |
| 2013-12-28 | (m) | $9.56B | $35.53M | $677.05M | $27.54M | (m) | 0.37% | 24.59× | Reported |
| 2013-09-28 | (m) | (m) | $30.14M | $671.51M | $30.91M | (m) | (m) | 21.72× | Reported |
| 2013-06-29 | (m) | (m) | $34.00M | $660.66M | $33.17M | (m) | (m) | 19.92× | Reported |
| 2013-03-30 | (m) | (m) | $33.87M | $639.29M | $35.99M | (m) | (m) | 17.76× | Reported |
| 2012-12-29 | (m) | (m) | $37.31M | $618.96M | $30.90M | (m) | (m) | 20.03× | Reported |
| 2012-09-29 | (m) | (m) | $42.75M | $600.99M | $30.24M | (m) | (m) | 19.88× | Reported |
| 2012-06-30 | (m) | (m) | $39.02M | $594.63M | $29.74M | (m) | (m) | 19.99× | Reported |
| 2012-03-31 | (m) | (m) | $37.34M | $591.14M | $29.93M | (m) | (m) | 19.75× | Reported |
| 2011-12-31 | (m) | (m) | $36.93M | $582.15M | $30.38M | (m) | (m) | 19.16× | Reported |
| 2011-09-24 | (m) | (m) | $36.21M | $560.77M | $30.34M | (m) | (m) | 18.48× | Reported |
| 2011-06-25 | (m) | (m) | $34.87M | $554.88M | $31.36M | (m) | (m) | 17.70× | Reported |
| 2011-03-26 | (m) | (m) | $32.11M | $541.67M | $32.64M | (m) | (m) | 16.60× | Reported |
| 2010-12-25 | (m) | (m) | $29.91M | $521.13M | $33.64M | (m) | (m) | 15.49× | Reported |
| 2010-09-25 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-26 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-27 | (m) | (m) | (m) | $477.26M | (m) | (m) | (m) | (m) | (m) |
| 2009-12-26 | (m) | (m) | $25.92M | $464.08M | $23.37M | (m) | (m) | 19.86× | Reported |
| 2009-09-26 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-27 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-27 | (m) | (m) | $25.43M | $419.29M | $34.60M | (m) | (m) | 12.12× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ (ACH) | United States | $0.057B | -0.87 |